Centocor ( CNTO ) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Centocor ( CNTO )

CNTO 0.00001000

0.0%

Jan 29 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: PawPr who wrote ()	4/21/1997 1:30:00 PM
From: FNS	of 965

Stock broke down on Friday....now know why! LLY reported ReoPro sales figures that the 'street' didn't like, indicated below: "ReoPro continued to show strong sales performance with sales for the first quarter of 1997 totaling $51.7 million, more than a two-fold increase from last year. During the first quarter, submissions were filed by Centocor, Inc., Lilly's collaboration partner, for expansion of ReoPro for use in all patients undergoing angioplasty and for use in stabilizing patients with unstable angina not responding to conventional therapy who are eligible for angioplasty." Anybody have any idea what 'anticipated' sales amount was??? Nothing announced by CNTO regarding this matter, that I know of. I believe CNTO QTR earnings due 5/5. Hope no further bad news...! Congratulations to those who went short .... hope you've covered... and Good Luck to all Longs. Still long! FNS

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next